We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- Genetic basis of cancer
- Oncogenes & tumour suppressors
- Sources of genetic mutations
- DNA repair failures & instability
- Multistep tumour progression & drivers
Talk Citation
(2025, October 30). Genetic basis of cancer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 30, 2025, from https://doi.org/10.69645/BGRU4128.Export Citation (RIS)
Publication History
- Published on October 30, 2025
Financial Disclosures
A selection of talks on Genetics & Epigenetics
Transcript
Please wait while the transcript is being prepared...
0:00
This session centres on Genetic Basis of
Cancer, offering a structured look
at the genetic foundations of cancer,
focusing on how mutations in oncogenes and
tumour suppressor genes disrupt normal cell regulation.
We will explore sources of
these mutations, including
both inherited predispositions and
environmental factors, and examine how failures
in DNA repair contribute to genomic instability.
Finally, we will discuss
the multistep process of tumour progression,
highlighting the role of driver mutations and
the resulting genetic diversity in
shaping cancer development and therapy challenges..
Cancer is fundamentally
a disease of the genome.
While many factors
contribute to cancer, it primarily arises from
accumulated genetic mutations that
disrupt normal regulation of
cell growth, survival, and differentiation.
These mutations occur in
two main classes of genes:
oncogenes, which promote
cell proliferation, and
tumour suppressor genes, which
restrain division or promote cell death.
When the balance
between these genes is
disturbed by mutations, cancer can develop.
Examining the types of
mutations and their effects on
cell function is essential to
understanding the genetic basis of cancer. Cell division is tightly regulated by cellular machinery. Oncogenes are mutated proto-oncogenes that become hyperactive, driving unchecked cell division through dominant mutations—one mutated copy is enough.
Tumour suppressor genes act as
brakes, halting division or triggering cell death;